Pharmacist Perceptions of Generic vs. Brand-Name Drugs: Survey Insights #2054879 (License: Personal Use)

This bar chart visualizes survey data from pharmacists evaluating eight statements about generic versus brand-name drugs, using a five-point Likert scale (strongly agree to strongly disagree). Key findings include high agreement that generics are therapeutically equivalent and less costly, but notable skepticism regarding perceived lower quality and higher adverse reactions. The strongest consensus is that generics meet the same safety requirements as branded counterparts.

Used in healthcare policy articles, pharmacy education resources, or patient-facing explainers to illustrate professional confidence in generic medications; matches user intent seeking evidence-based reassurance about generic drug reliability.